Surveillance for familial breast cancer: Differences in outcome according toBRCA mutation status-Reference-Cited by-同舟云学术

Surveillance for familial breast cancer: Differences in outcome according toBRCA mutation status

Published:2007 Issue:5 Volume:121 Page:1017-1020
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Moller Pal,Evans D. Gareth,Reis Marta M.,Gregory Helen,Anderson Elaine,Maehle Lovise,Lalloo Fiona,Howell Anthony,Apold Jaran,Clark Neal,Lucassen Anneke,Steel C. Michael

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Cancer of the breast and female reproductive tract. Ch. 93. In: Emery and Rimoin's principles and practice of medical genetics, 5th edn: , , , Eds. New York: Churchill Livingston, 2007. pp 2093–2121.

2. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

3. Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations

4. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of BRCA variation on prognosis in patients with nonmetastatic breast cancer;Annals of Human Genetics;2024-08-29

2. Comparison of Long-Term Oncological Results in Young Women with Breast Cancer between BRCA-Mutation Carriers Versus Non-Carriers: How Tumor and Genetic Risk Factors Influence the Clinical Prognosis;Cancers;2023-08-19

3. Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting;Cancers;2023-08-10

4. Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database;eClinicalMedicine;2023-04

5. Overexpression of tripartite motif-containing 47 (TRIM47) confers sensitivity to PARP inhibition via ubiquitylation of BRCA1 in triple negative breast cancer cells;Oncogenesis;2023-03-11